Niagen Bioscience, Inc. (NAGE) — Free Cash Flow Generation Index

Latest as of September 2025: 0.99x

Niagen Bioscience, Inc. (NAGE) has a Free Cash Flow Generation Index of 0.99x as of September 2025. Free cash flow of $3.67 Million represents 1% of operating cash flow ($3.69 Million). Explore reinvestment intensity of Niagen Bioscience, Inc. to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.99x
Free Cash Flow / Operating CF

Free Cash Flow

$3.67 Million
USD

Operating Cash Flow

$3.69 Million
USD

Capital Expenditures

$24.00K
USD

Niagen Bioscience, Inc. Free Cash Flow Generation Index (2023–2024)

Historical FCF Generation Index trend for Niagen Bioscience, Inc. across 2 annual periods. For the full cash flow conversion analysis, see how efficiently does Niagen Bioscience, Inc. generate cash.

Annual Free Cash Flow Generation for Niagen Bioscience, Inc. (2023–2024)

Year-by-year Free Cash Flow Generation Index for Niagen Bioscience, Inc.. Check Niagen Bioscience, Inc. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2024 0.99x $11.95 Million $12.11 Million $163.00K ▲ +0.7%
2023 0.98x $6.97 Million $7.12 Million $148.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).